SCHEMBL5772788

SCHEMBL5772788

[CH2]CC(C)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.50
C3AR1 Q16581 1/20 0.43
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
HIF1A Q16665 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC6A3 Q01959 2/20 0.40
SLC6A2 P23975 1/20 0.40
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
AOC3 Q16853 2/20 0.38
CYP2A6 P11509 1/20 0.38
BRD4 O60885 1/20 0.38
FFAR2 O15552 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
CYP19A1 P11511 1/20 0.37
SLC6A4 P31645 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11426669 0.85 IDO1 (0.41) MAPK1HIF1ALMNAHPGDIDO1
SCHEMBL1046241 0.82 ADRB2 (0.46) ADRB2C3AR1TSHRMAPK1HIF1A
SCHEMBL9180201 0.78 ACHE (0.48) TDP1IDO1SMN1; SMN2
SCHEMBL2632879 0.78 ADRB2 (0.52) ADRB2C3AR1TSHRMAPK1HIF1A
SCHEMBL14705838 0.78 ADRB2 (0.52) ADRB2C3AR1TSHRMAPK1HIF1A
SCHEMBL2931566 0.78 ADRB2 (0.52) ADRB2C3AR1TSHRMAPK1HIF1A
SCHEMBL10192291 0.78 ADRB2 (0.52) ADRB2C3AR1TSHRMAPK1HIF1A
SCHEMBL24616595 0.76 ADRB2 (0.50) ADRB2C3AR1TSHRMAPK1HIF1A
SCHEMBL21286098 0.76 TAAR1 (0.60) ADRB2C3AR1TSHRSLC6A3SLC6A2
SCHEMBL21286089 0.76 TAAR1 (0.60) ADRB2C3AR1TSHRSLC6A3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP claimed
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed
US-5502054-A LARVACIDES FOR INSECTS SUCH AS TOBACCO BUDWORM FMC CORPORATION (US) 1996-03-26 US disclosed
US-4029676-A ANTIADRENERGIC, ANTIFIBRILLATORY E. R. SQUIBB & SONS, INC. (US) 1977-06-14 US disclosed